Susan Smith

Signal Point Clinical Research Center, ...Middletown, Ohio - 45042 (513-423-0504) Signal Point Clinical Research CenterMiddletown, Ohio - 62801 Signal Point Clin Res Ctr ...Middletown, Ohio - 45042 (513-423-0504) |
- CLINICAL TRIALS 5
- CONDITIONS9
- INTERVENTIONS9
- SINCE2006

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
December 2006 - December 2011

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
June 2010 - June 2012

Study to Evaluate the Safety Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone Administered Intravenously to Patients With Colorectal Adenocarcinoma Previously Untreated for Metastatic Disease
May 2009 - December 2010

A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-Cell or Follicular Non-Hodgkin's Lymphoma (RATE)
July 2008 - February 2011

A Trial of Patients With Metastatic Adenocarcinoma of the Pancreas
March 2009 - June 2012
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Neoplasm Metastasis
Pancreatic Neoplasms
Carcinoma, Non-Small-Cell Lung
Colorectal Neoplasms
Lymphoma, Follicular
Placebo
Rituximab
Bavituximab
Ct-011
Gemcitabine
Stimuvax
Folfox
Paclitaxel / Carboplatin
Abi-007/Gemcitabine



